
Cigneon focuses on developing advanced therapies and tools to help healthcare providers treat difficult conditions. The company is building Viaspire, a drug/device in the pipeline, plus four other novel therapeutics. Core technology includes Paragon Engine, an AI-driven drug discovery platform that uses a Hidden Markov model to identify promising compounds. They are also developing an online networking tool for healthcare professionals. This combination targets B2B customers like clinics and hospitals, aiming to scale through AI, software tools, and a broader medical network.

Cigneon focuses on developing advanced therapies and tools to help healthcare providers treat difficult conditions. The company is building Viaspire, a drug/device in the pipeline, plus four other novel therapeutics. Core technology includes Paragon Engine, an AI-driven drug discovery platform that uses a Hidden Markov model to identify promising compounds. They are also developing an online networking tool for healthcare professionals. This combination targets B2B customers like clinics and hospitals, aiming to scale through AI, software tools, and a broader medical network.